upadacitinib,kpi-121
abbvie,kala pharmaceuticals
['ibd', ' upa ', ' uc ', 'stride-ii']
geert d haens presenting data of upa trials and uc symptom resolution and fatigue normalization.
#ecco2023 #ibd fatigue is definitely one of the biggest issues for many of our patients and we need to know how to handle it, how to improve it &amp;for sure to include it as an outcome 
Celebrate life. Gastroenterologist #IBD passionate. Help others grow their abilities. https://t.co/4V0xhhdIti